Intrexon | XON - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Agenus USD -199.08M 22.15M 2026-06
Alaunos Therapeutics USD 1.29M 865K 2026-03
Amgen USD 11.69B 2.5B 2026-06
Anika Therapeutics USD 137.28M 3.38M 2026-06
Arrowhead Research USD 465.53M 148.45M 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Gilead Sciences USD 11.74B 11.77B 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
Heron Therapeutics USD 6.91M 2.23M 2026-06
Incyte USD 6.34B 721.58M 2026-06
Intrexon USD 43.17M 75.33M 2024-06
Karyopharm Therapeutics USD -265.65M 27.28M 2026-03
Ligand Pharmaceuticals USD 967.52M 29.81M 2026-06
MacroGenics USD 42.87M 21.68M 2026-06
MannKind USD -67.2M 8M 2026-06
Merck USD 41.93B 3.94B 2026-06
Novartis USD 41.95B 3.02B 2026-06
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Roche Holding CHF 32.69B 1.11B 2026-06
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Veracyte USD 1.39B 44M 2026-06
Xencor USD 503.23M 12.4M 2026-06